CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.49B, above the global median of $1.18B
- PositionPrice-to-book is 0.99×, lower than 95% of its Medical Instruments & Supplies peers (median 2.98×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.49BUSDvs all stocks (USD)
Revenue (TTM)
613.81MUSDvs all stocks (USD)
Profit Margin
-20.02%vs Medical Instruments & Supplies peers
Beta
1.39xvs all stocks
52-Week Change
20.77%vs all stocks
Market Capitalization
1.49BUSDvs all stocks (USD)
Enterprise Value
1.22BUSDvs all stocks (USD)
Forward P/E
57.91xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.43xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.9859xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.99xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
36.92xvs Medical Instruments & Supplies peers
Gross Margin
44.89%vs Medical Instruments & Supplies peers
Profit Margin
-20.02%vs Medical Instruments & Supplies peers
Operating Margin
-2.27%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-0.73%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-7.04%vs Medical Instruments & Supplies peers
Revenue (TTM)
613.81MUSDvs all stocks (USD)
Revenue per Share (TTM)
13.41USDUpdated Sep 26, 2026Quarterly Revenue Growth
12.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
270.37MUSDvs all stocks (USD)
EBITDA (TTM)
184.97MUSDvs all stocks (USD)
Net Income (TTM)
-112.09MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
11.97%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
37.98MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
63.37MUSDvs all stocks (USD)
5-Year Average Dividend Yield
0.83%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
593.82MUSDFY2025 · Sep 30, 2025Cost of Goods Sold
323.54MUSDFY2025 · Sep 30, 2025Gross Profit
270.28MUSDFY2025 · Sep 30, 2025Operating Income
-21.67MUSDvs all stocks (USD)
Pre-tax Income
-7.14MUSDFY2025 · Sep 30, 2025Income Tax Expense
-31.60MUSDFY2025 · Sep 30, 2025Net Income
-55.76MUSDFY2025 · Sep 30, 2025EBIT
-21.67MUSDFY2025 · Sep 30, 2025EBITDA (Income Statement)
44.71MUSDFY2025 · Sep 30, 2025Research & Development
30.39MUSDFY2025 · Sep 30, 2025Selling, General & Administrative
261.56MUSDFY2025 · Sep 30, 2025Non-operating Interest Income
18.78MUSDFY2025 · Sep 30, 2025EPS (Basic)
-1.22USDFY2025 · Sep 30, 2025EPS (Diluted)
-1.22USDFY2025 · Sep 30, 2025Basic Shares Outstanding
45.74MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
45.74MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
-55.76MUSDFY2025 · Sep 30, 2025Operating Cash Flow
-30.54MUSDFY2025 · Sep 30, 2025Free Cash Flow
-64.40MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
296.69MUSDFY2025 · Sep 30, 2025Income Tax Paid
6.57MUSDFY2025 · Sep 30, 2025Starting Profit (CF Statement)
-55.76MUSDFY2025 · Sep 30, 2025Depreciation & Amortization
61.21MUSDFY2025 · Sep 30, 2025Deferred Taxes (CF)
-27.04MUSDFY2025 · Sep 30, 2025Stock-based Compensation
20.88MUSDFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
-24.56MUSDFY2025 · Sep 30, 2025Change in Accounts Payable (CF)
1.04MUSDFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
-6.30MUSDFY2025 · Sep 30, 2025Capital Expenditures
-33.86MUSDFY2025 · Sep 30, 2025Net Acquisitions
0.00USDFY2025 · Sep 30, 2025Purchase of Investments
-451.41MUSDFY2025 · Sep 30, 2025Sale of Investments
394.81MUSDFY2025 · Sep 30, 2025Net Investing Cash Flow
-90.46MUSDFY2025 · Sep 30, 2025Long-term Debt Payments
-985.00KUSDFY2025 · Sep 30, 2025Common Stock Repurchase
0.00USDFY2025 · Sep 30, 2025Other Financing Charges
-11.38MUSDFY2025 · Sep 30, 2025Net Financing Cash Flow
-9.59MUSDFY2025 · Sep 30, 2025Shares Outstanding
43.76MSharesUpdated Sep 26, 2026Float Shares
38.88MSharesUpdated Sep 26, 2026Shares Short
5.38MSharesUpdated Sep 26, 2026Short Ratio
6.57daysvs all stocks
Short % of Shares Outstanding
19.95%vs all stocks
% Held by Insiders
1.36%vs all stocks
% Held by Institutions
117.26%vs all stocks
Total Cash (MRQ)
325.80MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
7.44USDUpdated Sep 26, 2026Total Debt (MRQ)
53.97MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0357xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.50xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
34.51USDUpdated Sep 26, 2026Total Assets
2.06BUSDvs all stocks (USD)
Total Current Assets
708.34MUSDFY2025 · Sep 30, 2025Total Liabilities
332.60MUSDFY2025 · Sep 30, 2025Total Non-current Assets
1.35BUSDFY2025 · Sep 30, 2025Total Non-current Liabilities
94.92MUSDFY2025 · Sep 30, 2025Total Current Liabilities
237.67MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents
279.78MUSDFY2025 · Sep 30, 2025Other Short-term Investments
61.14MUSDFY2025 · Sep 30, 2025Accounts Receivable
142.18MUSDFY2025 · Sep 30, 2025Inventory
74.96MUSDFY2025 · Sep 30, 2025Accounts Payable
37.72MUSDFY2025 · Sep 30, 2025Deferred Revenue
58.07MUSDFY2025 · Sep 30, 2025Other Current Liabilities
61.69MUSDFY2025 · Sep 30, 2025Long-term Debt
51.24MUSDFY2025 · Sep 30, 2025Other Non-current Liabilities
11.14MUSDFY2025 · Sep 30, 2025Common Stock (Book)
594.00KUSDFY2025 · Sep 30, 2025Retained Earnings
1.42BUSDFY2025 · Sep 30, 2025Total Shareholders' Equity
1.73BUSDvs all stocks (USD)
Treasury Stock
200.96MUSDFY2025 · Sep 30, 202552-Week Low
15.93USDUpdated Sep 26, 202652-Week High
41.73USDUpdated Sep 26, 202652-Week Change
20.77%vs all stocks
Beta
1.39xvs all stocks
50-Day MA
31.68USDUpdated Sep 26, 2026200-Day MA
28.19USDUpdated Sep 26, 2026Avg 10-Day Volume
863.64KSharesUpdated Sep 26, 2026Avg 30-Day Volume
831.11KSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-2.47USDUpdated Sep 26, 2026Other Income / Expense
-4.25MUSDFY2025 · Sep 30, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.99×, lower than 95% of its Medical Instruments & Supplies peers (median 2.98×)Notable
Price-to-book: 0.99Industry median: 2.98Industry P5: 1.11Peers compared: 38.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.45Profit Margin: -0.20
Financial Health
Altman Z-Score 4.18: safe zoneNotable
Altman Z-Score: 4.18
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.49B, above the global median of $1.18BNotable
Market cap (USD): 1,490,361,529Global Median: 1,180,223,658.953
Revenue is $613.81M, above the global median of $548.88MNotable
Revenue (USD): 613,806,976Global Median: 548,883,780.48
Levered free cash flow is $63.37M, above the global median of $18.73MNotable
Levered free cash flow (USD): 63,366,000Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Corbion N.V.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kirloskar Brothers Limited
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Eaglerise Electric & Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Rainbow Children's Medicare Pvt. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Triangle Tyre Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
JBM Auto Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Anjie Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Ardent Health Partners Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Sino Geophysical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Datang Telecom Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule